Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Anti-idiotypic
Patent
1979-10-01
1982-01-12
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Anti-idiotypic
A61K 3324
Patent
active
043105157
ABSTRACT:
A stable, sterile aqueous solution of cisplatin in a sealed container such as an ampul or vial in unit dosage form suitable for intravenous administration to man is provided which has a concentration of cisplatin between about 0.1 and about 1.0 mgm./ml. and a pH in the range of 2.0 to 3.0 or preferably about 2.5. It can also contain sodium chloride and mannitol.
REFERENCES:
Handelman et al., Cancer Therapy Evaluation Program, Div. of Cancer Treatment, National Cancer Ins. (Aug. 1974) pp. 1-5 and 31-32.
Rossoe et al., Cancer 30 pp. 1451-1456 (1972).
Rozencweig et al., Annals of Internal Med., 86 pp. 803-812 (1977).
Grab Frederick L.
Granatek Edmund S.
Ziemba Gerald M.
Bristol-Myers Company
Goldberg Jerome D.
Taylor, Jr. Herbert W.
LandOfFree
Pharmaceutical compositions of cisplatin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions of cisplatin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions of cisplatin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1540984